CLINICAL_TRIALS
trial_result
· 2024-08-09
Clinical Trial Update: Nesvategrast (OTT166) in Diabetic Retinopathy (DR) [Phase 2]
Summary
Phase 2 trial of Nesvategrast (OTT166) for diabetic retinopathy has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OcuTerra Therapeutics, Inc. | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2024-08-09